{"id":331383,"date":"2026-10-29T11:27:00","date_gmt":"2026-10-29T05:57:00","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=331383"},"modified":"2026-10-29T11:27:00","modified_gmt":"2026-10-29T05:57:00","slug":"midcap-lic-portfolio-stocks-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/","title":{"rendered":"4 Midcap LIC Portfolio Stocks to Watch for Future Multibagger Potential: Lupin, Max Healthcare, Mphasis and Navin Fluorine"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Lupin Rs 1,972.70. Max Healthcare Rs 851.50. Mphasis Rs 2,518. Navin Fluorine Rs 8,501. Market caps from Rs 44,095 crore to Rs 91,955 crore. Data as of 28 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Lupin, Max Healthcare, Mphasis and Navin Fluorine are the 4 picks in this LIC portfolio stocks watchlist, with market caps between Rs 44,095 crore and Rs 91,955 crore. Lupin stands out for the highest return on equity at 23.76%, while Max Healthcare offers the biggest five-year price gain at 149.91%. PE ratios run from 16.57 to 59.66, so compare each one with its industry PE before investing. All figures are as of 28 October 2026.<\/p>\n<\/p><\/div>\n<p>LIC portfolio stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Lupin, Max Healthcare, Mphasis and Navin Fluorine meet that test, with market caps from Rs 44,095 crore to Rs 91,955 crore and Lupin offering the highest return on equity at 23.76%. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and LIC listed among its top domestic institutional holders, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.<\/p>\n<p>This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and LIC listed among its top domestic institutional holders, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening LIC portfolio stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 28 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=lic-portfolio-stocks\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#What_Are_LIC_Portfolio_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\" title=\"What Are LIC Portfolio Stocks and Why Do They Attract Multibagger Interest?\">What Are LIC Portfolio Stocks and Why Do They Attract Multibagger Interest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#LIC_Portfolio_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\" title=\"LIC Portfolio Stocks at a Glance: Price, Market Cap, PE and ROE\">LIC Portfolio Stocks at a Glance: Price, Market Cap, PE and ROE<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#Lupin_Revenue_Up_2676_in_FY26\" title=\"Lupin: Revenue Up 26.76% in FY26\">Lupin: Revenue Up 26.76% in FY26<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#Max_Healthcare_2426_Profit_CAGR_Since_FY22\" title=\"Max Healthcare: 24.26% Profit CAGR Since FY22\">Max Healthcare: 24.26% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#Mphasis_Profit_Compounding_at_681_a_Year\" title=\"Mphasis: Profit Compounding at 6.81% a Year\">Mphasis: Profit Compounding at 6.81% a Year<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#Navin_Fluorine_2602_Profit_CAGR_Since_FY22\" title=\"Navin Fluorine: 26.02% Profit CAGR Since FY22\">Navin Fluorine: 26.02% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#LIC_Portfolio_Stocks_Financial_Comparison_on_Growth_and_Margins\" title=\"LIC Portfolio Stocks: Financial Comparison on Growth and Margins\">LIC Portfolio Stocks: Financial Comparison on Growth and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#Institutional_Holding_in_Lupin_Max_Healthcare_Mphasis_and_Navin_Fluorine\" title=\"Institutional Holding in Lupin, Max Healthcare, Mphasis and Navin Fluorine\">Institutional Holding in Lupin, Max Healthcare, Mphasis and Navin Fluorine<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#Risks_to_Weigh_in_LIC_Portfolio_Stocks\" title=\"Risks to Weigh in LIC Portfolio Stocks\">Risks to Weigh in LIC Portfolio Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#How_to_Choose_Between_LIC_Portfolio_Stocks\" title=\"How to Choose Between LIC Portfolio Stocks\">How to Choose Between LIC Portfolio Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#Frequently_Asked_Questions_on_LIC_Portfolio_Stocks_to_Watch\" title=\"Frequently Asked Questions on LIC Portfolio Stocks to Watch\">Frequently Asked Questions on LIC Portfolio Stocks to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#Which_are_the_best_LIC_portfolio_stocks_to_watch_for_multibagger_potential\" title=\"Which are the best LIC portfolio stocks to watch for multibagger potential?\">Which are the best LIC portfolio stocks to watch for multibagger potential?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#Is_Lupin_a_good_stock_for_long-term_investors\" title=\"Is Lupin a good stock for long-term investors?\">Is Lupin a good stock for long-term investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#Can_Navin_Fluorine_become_a_multibagger_from_here\" title=\"Can Navin Fluorine become a multibagger from here?\">Can Navin Fluorine become a multibagger from here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#What_is_the_market_cap_of_Lupin_Max_Healthcare_Mphasis_and_Navin_Fluorine\" title=\"What is the market cap of Lupin, Max Healthcare, Mphasis and Navin Fluorine?\">What is the market cap of Lupin, Max Healthcare, Mphasis and Navin Fluorine?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#What_are_the_risks_of_investing_in_LIC_portfolio_stocks\" title=\"What are the risks of investing in LIC portfolio stocks?\">What are the risks of investing in LIC portfolio stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#Why_is_Navin_Fluorine_trading_at_a_PE_of_5584\" title=\"Why is Navin Fluorine trading at a PE of 55.84?\">Why is Navin Fluorine trading at a PE of 55.84?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/midcap-lic-portfolio-stocks-to-watch-multibagger-potential\/#How_much_do_institutions_hold_in_Lupin_Max_Healthcare_Mphasis_and_Navin_Fluorine\" title=\"How much do institutions hold in Lupin, Max Healthcare, Mphasis and Navin Fluorine?\">How much do institutions hold in Lupin, Max Healthcare, Mphasis and Navin Fluorine?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_LIC_Portfolio_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\"><\/span><strong>What Are LIC Portfolio Stocks and Why Do They Attract Multibagger Interest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>LIC portfolio stocks are shares of mid sized companies in which Life Insurance Corporation of India, the largest domestic institutional investor, is named among the top holders in the latest shareholding pattern. The four here cover pharmaceuticals, hospitals, IT services and specialty chemicals.<\/p>\n<p>When a patient investor like LIC ranks among the largest holders of a company, it shows deep confidence in the business from an institution that invests for decades. For LIC portfolio stocks, both FY26 and the latest quarter showed growth. For LIC portfolio stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of LIC portfolio stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for LIC portfolio stocks before you decide.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"LIC_Portfolio_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\"><\/span><strong>LIC Portfolio Stocks at a Glance: Price, Market Cap, PE and ROE<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prices are closing prices as of 28 October 2026. Lupin combines the lowest PE of the group, 16.57, with the highest return on equity, 23.76%.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Industry PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">52-Week Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/lupin\/lupin-ltd-share-price-today\">Lupin<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,972.70<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">91,955<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.57<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.76%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.29<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,900.00 to 2,529.50<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/maxhealth\/max-healthcare-institute-ltd-share-price-today\">Max Healthcare Institute<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">851.50<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">86,925<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">59.66<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">60.75<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.42%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.32<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">815.00 to 1,221.90<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/mphasis\/mphasis-ltd-share-price-today\">Mphasis<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,518<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">47,225<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24.72<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">18.49<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.34%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.24<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,013.00 to 2,975.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/navinfluor\/navin-fluorine-international-ltd-share-price-today\">Navin Fluorine International<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8,501<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">44,095<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">55.84<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.69%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.32<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,772.20 to 8,949.50<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Lupin_Revenue_Up_2676_in_FY26\"><\/span><strong>Lupin: Revenue Up 26.76% in FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Lupin is a global pharmaceutical company with a large presence in the United States, India and other markets across generics, branded drugs and respiratory products. It reported FY26 revenue of Rs 29,038.95 crore, up 26.76% year on year, and net profit of Rs 5,355.47 crore, up 61.98%. Revenue has compounded at 14.98% a year since FY22. Operating margin was 31.06% in FY26. The debt-to-equity ratio is 0.29.<\/p>\n<p>In the June 2026 quarter, revenue rose 32.45% to Rs 8,407.21 crore and net profit grew 16.01% to Rs 1,416.98 crore. The share price has gained 111.00% over five years. Foreign investors raised their holding from 21.25% in June 2025 to 22.42% in June 2026. The stock trades at a PE of 16.57 against an industry PE of 36.42, below the sector average, with a return on equity of 23.76%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Max_Healthcare_2426_Profit_CAGR_Since_FY22\"><\/span><strong>Max Healthcare: 24.26% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Max Healthcare Institute runs a network of multi-speciality hospitals in Delhi NCR, Mumbai and other cities. It reported FY26 revenue of Rs 8,536.07 crore, up 18.82% year on year, and net profit of Rs 1,442.41 crore, up 34.07%. Net profit has compounded at 24.26% a year since FY22, while revenue has grown 20.42% a year. Operating margin was 28.15% in FY26. The debt-to-equity ratio is 0.32.<\/p>\n<p>The stock trades at a PE of 59.66 against an industry PE of 60.75, below the sector average, with a return on equity of 13.42%. In the June 2026 quarter, revenue rose 16.60% to Rs 2,406.69 crore and net profit grew 4.87% to Rs 322.96 crore. The share price has gained 149.91% over five years. Domestic institutions raised their holding from 17.42% in June 2025 to 29.96% in June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Mphasis_Profit_Compounding_at_681_a_Year\"><\/span><strong>Mphasis: Profit Compounding at 6.81% a Year<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Mphasis provides IT, cloud and application services to banking, insurance and technology clients. It reported FY26 revenue of Rs 16,205.54 crore, up 11.88% year on year, and net profit of Rs 1,862.60 crore, up 9.43%. Net profit has compounded at 6.81% a year since FY22, while revenue has grown 7.53% a year. Operating margin was 20.58% in FY26. The debt-to-equity ratio is 0.24.<\/p>\n<p>In the June 2026 quarter, revenue rose 17.14% to Rs 4,466.91 crore and net profit grew 10.82% to Rs 489.51 crore. Domestic institutions raised their holding from 37.07% in September 2025 to 45.85% in September 2026. The stock trades at a PE of 24.72 against an industry PE of 18.49, with a return on equity of 17.34%. The dividend yield is 2.50%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Navin_Fluorine_2602_Profit_CAGR_Since_FY22\"><\/span><strong>Navin Fluorine: 26.02% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Navin Fluorine International makes specialty fluorochemicals, refrigerant gases and contract research and manufacturing services. It reported FY26 revenue of Rs 3,379.19 crore, up 41.20% year on year, and net profit of Rs 663.56 crore, up 129.92%. Net profit has compounded at 26.02% a year since FY22, while revenue has grown 22.66% a year. Operating margin was 34.41% in FY26. The debt-to-equity ratio is 0.32.<\/p>\n<p>The stock trades at a PE of 55.84 against an industry PE of 36.42, with a return on equity of 16.69%. In the June 2026 quarter, revenue rose 46.11% to Rs 1,080.17 crore and net profit grew 107.66% to Rs 243.31 crore. The share price has gained 111.47% over five years and 61.62% over the past year. Foreign investors raised their holding from 21.98% in July 2025 to 23.73% in June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"LIC_Portfolio_Stocks_Financial_Comparison_on_Growth_and_Margins\"><\/span><strong>LIC Portfolio Stocks: Financial Comparison on Growth and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares scale and growth across these LIC portfolio stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Revenue CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Latest Quarter Revenue Growth<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Operating Margin (Latest Quarter)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Lupin<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">29,038.95<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5,355.47<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">26.76%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.98%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.45%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">31.40%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Max Healthcare<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8,536.07<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,442.41<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">18.82%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.42%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.60%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">27.00%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Mphasis<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16,205.54<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,862.60<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.88%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.14%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.04%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Navin Fluorine<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,379.19<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">663.56<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">41.20%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">22.66%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">46.11%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">37.52%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these LIC portfolio stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_in_Lupin_Max_Healthcare_Mphasis_and_Navin_Fluorine\"><\/span><strong>Institutional Holding in Lupin, Max Healthcare, Mphasis and Navin Fluorine<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding shows who is backing these LIC portfolio stocks alongside the promoter. The table uses the latest reported quarter for each. Max Healthcare has the deepest institutional backing, with FII and DII together holding 71.74% as of June 2026. Domestic institutions increased their holding over the past year in Max Healthcare (from 17.42% to 29.96%) and Mphasis (from 37.07% to 45.85%).<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Promoter<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">FII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">DII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Public<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Quarter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Lupin<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">46.85%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">22.42%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24.65%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">6.08%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Max Healthcare<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.71%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">41.78%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">29.96%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4.56%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Mphasis<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">30.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">19.39%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">45.85%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4.23%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Navin Fluorine<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">27.08%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.73%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">28.46%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.73%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_in_LIC_Portfolio_Stocks\"><\/span><strong>Risks to Weigh in LIC Portfolio Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Being careful with LIC portfolio stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:<\/p>\n<ul>\n<li>Past growth may not repeat.<\/li>\n<li>Share prices can move sharply in either direction.<\/li>\n<li><strong>Valuation:<\/strong> Navin Fluorine trades at a PE of 55.84 against an industry PE of 36.42, so earnings need to keep growing to support the price.<\/li>\n<li><strong>Concentration:<\/strong> Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Between_LIC_Portfolio_Stocks\"><\/span><strong>How to Choose Between LIC Portfolio Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Picking from LIC portfolio stocks comes down to four checks, applied in order.<\/p>\n<ol>\n<li>Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.<\/li>\n<li>Compare each PE with the industry PE (18.49 to 60.75) and ask whether the growth rate justifies any gap.<\/li>\n<li>Track net profit growth, the operating margin and the return on equity in every quarterly result.<\/li>\n<li>Stagger entries across quarters and review institutional holding every reporting season.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Lupin, Max Healthcare, Mphasis and Navin Fluorine live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among LIC portfolio stocks, Lupin stands out for the highest return on equity at 23.76%, Max Healthcare for the biggest five-year price gain at 149.91%, Mphasis for 11.88% revenue growth in FY26 and Navin Fluorine for the fastest profit growth, 26.02% a year since FY22. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing LIC portfolio stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_LIC_Portfolio_Stocks_to_Watch\"><\/span><strong>Frequently Asked Questions on LIC Portfolio Stocks to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_LIC_portfolio_stocks_to_watch_for_multibagger_potential\"><\/span><strong>Which are the best LIC portfolio stocks to watch for multibagger potential?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Lupin, Max Healthcare, Mphasis and Navin Fluorine are the 4 names this list highlights, with market caps of Rs 91,955 crore, Rs 86,925 crore, Rs 47,225 crore and Rs 44,095 crore respectively. Lupin is notable for the highest return on equity at 23.76%. Max Healthcare stands out for the biggest five-year price gain at 149.91%. Mphasis offers 11.88% revenue growth in FY26. Navin Fluorine brings the fastest profit growth, 26.02% a year since FY22. These are watchlist names for LIC portfolio stocks, not recommendations, so match each one to your own risk profile and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Lupin_a_good_stock_for_long-term_investors\"><\/span><strong>Is Lupin a good stock for long-term investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Lupin has a return on equity of 23.76%, a PE of 16.57 against an industry PE of 36.42 and a market cap of Rs 91,955 crore. FY26 revenue rose 26.76%, and June 2026 quarter net profit grew 16.01%. Long-term returns in LIC portfolio stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Navin_Fluorine_become_a_multibagger_from_here\"><\/span><strong>Can Navin Fluorine become a multibagger from here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Navin Fluorine has already gained 111.47% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in LIC portfolio stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 26.02% a year since FY22, and FY26 revenue rose 41.20%. At a PE of 55.84 against an industry PE of 36.42, valuation should be checked against that growth before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Lupin_Max_Healthcare_Mphasis_and_Navin_Fluorine\"><\/span><strong>What is the market cap of Lupin, Max Healthcare, Mphasis and Navin Fluorine?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 28 October 2026, Lupin has a market cap of Rs 91,955 crore, Max Healthcare has a market cap of Rs 86,925 crore, Mphasis has a market cap of Rs 47,225 crore and Navin Fluorine has a market cap of Rs 44,095 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on LIC portfolio stocks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_LIC_portfolio_stocks\"><\/span><strong>What are the risks of investing in LIC portfolio stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Navin Fluorine trades at a PE of 55.84 against an industry PE of 36.42, so earnings growth needs to hold up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Navin_Fluorine_trading_at_a_PE_of_5584\"><\/span><strong>Why is Navin Fluorine trading at a PE of 55.84?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Navin Fluorine&#8217;s PE of 55.84 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 16.69%, profit growth of 26.02% a year since FY22 and latest-quarter profit growth of 107.66%, which also means the stock is more sensitive if growth slows. Investors in LIC portfolio stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_do_institutions_hold_in_Lupin_Max_Healthcare_Mphasis_and_Navin_Fluorine\"><\/span><strong>How much do institutions hold in Lupin, Max Healthcare, Mphasis and Navin Fluorine?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest reported quarter, FII and DII together hold 47.07% of Lupin (22.42% and 24.65%), 71.74% of Max Healthcare (41.78% and 29.96%), 65.24% of Mphasis (19.39% and 45.85%) and 52.19% of Navin Fluorine (23.73% and 28.46%). Rising institutional holding is a useful signal in LIC portfolio stocks, though it should be read with earnings trends rather than on its own.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best LIC portfolio stocks to watch for multibagger potential?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Lupin, Max Healthcare, Mphasis and Navin Fluorine are the 4 names this list highlights, with market caps of Rs 91,955 crore, Rs 86,925 crore, Rs 47,225 crore and Rs 44,095 crore respectively. Lupin is notable for the highest return on equity at 23.76%. Max Healthcare stands out for the biggest five-year price gain at 149.91%. Mphasis offers 11.88% revenue growth in FY26. Navin Fluorine brings the fastest profit growth, 26.02% a year since FY22. These are watchlist names for LIC portfolio stocks, not recommendations, so match each one to your own risk profile and time horizon.\"}},{\"@type\":\"Question\",\"name\":\"Is Lupin a good stock for long-term investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Lupin has a return on equity of 23.76%, a PE of 16.57 against an industry PE of 36.42 and a market cap of Rs 91,955 crore. FY26 revenue rose 26.76%, and June 2026 quarter net profit grew 16.01%. Long-term returns in LIC portfolio stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.\"}},{\"@type\":\"Question\",\"name\":\"Can Navin Fluorine become a multibagger from here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Navin Fluorine has already gained 111.47% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in LIC portfolio stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 26.02% a year since FY22, and FY26 revenue rose 41.20%. At a PE of 55.84 against an industry PE of 36.42, valuation should be checked against that growth before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Lupin, Max Healthcare, Mphasis and Navin Fluorine?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 28 October 2026, Lupin has a market cap of Rs 91,955 crore, Max Healthcare has a market cap of Rs 86,925 crore, Mphasis has a market cap of Rs 47,225 crore and Navin Fluorine has a market cap of Rs 44,095 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on LIC portfolio stocks.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in LIC portfolio stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Navin Fluorine trades at a PE of 55.84 against an industry PE of 36.42, so earnings growth needs to hold up.\"}},{\"@type\":\"Question\",\"name\":\"Why is Navin Fluorine trading at a PE of 55.84?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Navin Fluorine's PE of 55.84 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 16.69%, profit growth of 26.02% a year since FY22 and latest-quarter profit growth of 107.66%, which also means the stock is more sensitive if growth slows. Investors in LIC portfolio stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.\"}},{\"@type\":\"Question\",\"name\":\"How much do institutions hold in Lupin, Max Healthcare, Mphasis and Navin Fluorine?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest reported quarter, FII and DII together hold 47.07% of Lupin (22.42% and 24.65%), 71.74% of Max Healthcare (41.78% and 29.96%), 65.24% of Mphasis (19.39% and 45.85%) and 52.19% of Navin Fluorine (23.73% and 28.46%). Rising institutional holding is a useful signal in LIC portfolio stocks, though it should be read with earnings trends rather than on its own.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 midcap LIC portfolio stocks compared on market cap, PE, ROE, growth and institutional holding: Lupin, Max Healthcare, Mphasis and Navin Fluorine.<\/p>\n","protected":false},"author":33,"featured_media":331382,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[17641,17640],"class_list":["post-331383","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-lic-portfolio-sector","tag-lic-portfolio-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["331382"],"rank_math_title":["LIC Portfolio Stocks 2026: Lupin, Max Healthcare"],"rank_math_description":["LIC portfolio stocks to watch for multibagger potential: Lupin, Max Healthcare, Mphasis and Navin Fluorine. Compare market cap, PE, ROE, growth and institutional holding."],"rank_math_focus_keyword":["LIC portfolio stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/4-midcap-lic-portfolio-stocks-to-watch-for-future-multibagger-potential-lupin.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/331383","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=331383"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/331383\/revisions"}],"predecessor-version":[{"id":331384,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/331383\/revisions\/331384"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/331382"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=331383"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=331383"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=331383"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}